YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy). (Q38381824)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 January 2017
edit
Language Label Description Also known as
English
YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy).
scientific article published on 24 January 2017

    Statements

    YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy). (English)
    Junya Aoki
    Kazumi Kimura
    Naomi Morita
    Masafumi Harada
    Norifumi Metoki
    Yohei Tateishi
    Kenichi Todo
    Hiroshi Yamagami
    Kouji Hayashi
    Yuka Terasawa
    Koji Fujita
    Nobuaki Yamamoto
    Ichiro Deguchi
    Norio Tanahashi
    Takeshi Inoue
    Takeshi Iwanaga
    Nobuyuki Kaneko
    Hidetaka Mitsumura
    Yasuyuki Iguchi
    Yasushi Ueno
    Yoji Kuramoto
    Toshiyasu Ogata
    Shigeru Fujimoto
    Mutsumi Yokoyama
    Shinji Nagahiro
    YAMATO Study Investigators
    24 January 2017
    712-719

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit